Pricing

Log inSign up

Lycia Therapeutics

1 follower

‌

We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

11-50

Links


Org chart

Aetna Wun Trombley
President & CEO
Collapse
Steve Staben
Chief Scientific Officer
Winsome Chung
VP, Finance
Darrin Lindhout
Head of Biologics
CL
Chin Lee
Chief Medical Officer

Board & advisors

WR
William J. Rieflin
Chair
TA
Tim Anderson
Director
MF
Ming Fang
Director
Laurent Fischer
Director
CO
Clare Ozawa
Director
TW
Tom Woiwode
Director
CB
Carolyn Bertozzi
Chair
Monther Abu-Remaileh
Scientific Advisory Board
MD
Mark M. Davis
Advisor
RS
Randy Schekman
Advisor
AS
Alanna Schepartz
Advisor
DH
Daniel D. Von Hoff
Advisor

Teams

+7

Scientific Research Team

11 people · 0 jobs

CO
MF
TA
+2

Directors Team

6 people · 0 jobs

Research and Development

4 people · 0 jobs

AS
DH
MD
+1

Advisory Team

5 people · 0 jobs

Leadership Team

2 people · 0 jobs


Offices

  • HQ

    12 positions, 0 job posts

    +8

Similar companies

Tango Therapeutics

3 followers

Cellares

4 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

27 followers

Cytiva

14 followers

PerkinElmer

11 followers

Explore companies

Company
AboutContactTrust
Product
LearnExploreIterate
Business
PricingVerificationLicense
Enrich
LinkedIn ExtensionCRM EnrichmentDeveloper Portal
Social
© 2025 Orgio, Inc.
Terms
Privacy
Do not sell my info